Harnessing Antigen Specific CAR-Treg Cells for Enhanced Specificity Autoimmune Diseases
Time: 8:30 am
day: Custom Day Two
Details:
• Engineering CAR-Treg cells that recognize self-antigen specific to the site of inflammation
• CAR-Tregs to enhance localization and the potency of Treg therapies to treat inflammatory bowel disease
• Discuss the potential advantages of antigen-specific CAR-Treg cells compared to Polyclonal Treg therapies
